SCINAI IMMUNOTHERAPEUTICS LTD. Increase (Decrease) in Other Accounts Payable
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Increase (Decrease) in Other Accounts Payable of -$157.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayable · last filed 2026-04-01
- SCINAI IMMUNOTHERAPEUTICS LTD. increase (decrease) in other accounts payable for the quarter ending 2023-06-30 was $22.00K.
- SCINAI IMMUNOTHERAPEUTICS LTD. increase (decrease) in other accounts payable for the quarter ending 2023-03-31 was -$369.00K, a 567.09% decline year-over-year.
- SCINAI IMMUNOTHERAPEUTICS LTD. increase (decrease) in other accounts payable for the quarter ending 2022-06-30 was -$516.00K.
- SCINAI IMMUNOTHERAPEUTICS LTD. increase (decrease) in other accounts payable for the quarter ending 2022-03-31 was $79.00K.
| Period end | Increase (Decrease) in Other Accounts Payable 3 month | Increase (Decrease) in Other Accounts Payable 6 month | Increase (Decrease) in Other Accounts Payable 12 month |
|---|---|---|---|
| 2025-12-31 | -$157.00K 20-F · filed 2026-04-01 | ||
| 2025-06-30 | -$42.00K 6-K · filed 2025-09-02 | ||
| 2024-12-31 | $157.00K 20-F · filed 2026-04-01 | ||
| 2024-06-30 | -$199.00K 6-K · filed 2025-09-02 | ||
| 2023-12-31 | -$341.00K 20-F · filed 2026-04-01 | ||
| 2023-06-30 | $22.00K derived: 6-K 6 month − 10-Q 3 month · filed 2024-09-09 | -$347.00K 6-K · filed 2024-09-09 | |
| 2023-03-31 | -$369.00K 10-Q · filed 2023-05-15 | ||
| 2022-12-31 | $309.00K 20-F · filed 2025-05-07 | ||
| 2022-06-30 | -$516.00K derived: 6-K/A 6 month − 10-Q 3 month · filed 2023-08-18 | -$437.00K 6-K/A · filed 2023-08-18 | |
| 2022-03-31 | $79.00K 10-Q · filed 2023-05-15 | ||
| 2021-12-31 | $644.00K 20-F · filed 2024-05-15 |